- Report
- February 2025
- 200 Pages
Global
From €4293EUR$4,490USD£3,593GBP
- Report
- January 2025
- 282 Pages
Global
From €4780EUR$5,000USD£4,002GBP
- Report
- April 2024
- 160 Pages
Global
From €4751EUR$4,969USD£3,977GBP
- Book
- April 2018
- 560 Pages
- Book
- April 2013
- 412 Pages
Rett Syndrome is a rare neurological disorder that affects the development of the brain in children, primarily girls. It is characterized by a period of normal development followed by a regression of language, motor, and social skills. Symptoms include repetitive hand movements, breathing irregularities, and seizures. Treatment focuses on managing symptoms and improving quality of life.
The Rett Syndrome market is a subset of the larger Neurology market. It is a small but growing market, with a focus on developing treatments and therapies to improve the lives of those affected. Research and development efforts are ongoing, with a focus on developing new treatments and therapies.
Companies in the Rett Syndrome market include Biomarin Pharmaceuticals, Inc., PTC Therapeutics, Inc., and Rettsyndrome.org. Show Less Read more